Study: CBD-Based Therapy May Help Treat Schizophrenia

Study: CBD-Based Therapy May Help Treat Schizophrenia

For years the faulty argument has been made that cannabis causes and/or increases the likelihood of schizophrenia. Of course, much of this position has already been debunked in one way or another. A study published in 2004 determined that cannabis can help counter psychosis; another study published last year found that cannabidiol (CBD) can help improve cognitive function in schizophrenic individuals.

Accordingly, a number of researchers seem to have experienced a change of heart, and are looking to investigate the potential role of cannabis in schizophrenia therapy. A group of Brazilian researchers, led by Raquel Levin and Fernanda F. Peres, published a study last month in the journal Frontiers in Pharmacology that sheds further light on the matter, investigating an assortment of cannabinoid treatments.

Researchers Investigate Cannabinoid Therapy For Schizophrenia

Schizophrenia is a chronic psychological disorder that affects around one percent of the American population. There are a number of signs and symptoms of the condition, but it is most often associated with hallucinations/delusions, disorganized thinking, and anhedonia (lack of pleasure for everyday life).

There is no cure for schizophrenia, and existing treatments are primarily aimed at controlling symptoms. Many of the treatments commonly used have the potential to cause a laundry list of side effects, including increased sensitivity to light, seizures, and attention deficits.

“WIN55212,2 and cannabidiol (CBD) proved to successfully reverse any sensory gating deficits in the schizophrenic mice.”

Using a specific strain of rats as an experimental model, the Brazilian research team investigated an assortment of cannabinoid treatments.

These include: WIN55212,2 (synthetic cannabinoid agonist), rimonabant (synthetic CB1 antagonist), AM404 (anandamide uptake inhibitor), and cannabidiol (CBD).

cbd moleculeThe researchers were particularly interested whether treatment would improve sensory gating, which is essentially the brain’s ability to block out unnecessary stimulation (e.g. constant humming from the air conditioner). With that said, they administered each cannabinoid in varying doses in order to determine the superior route of treatment.

According to their results, 1 mg/kg of WIN55212,2 proved to successfully reverse any sensory gating deficits in the schizophrenic mice. The same effect was reached with 30 mg/kg of cannabidiol (CBD), which has been the center of attention as far as cannabinoids are concerned. This is largely due to the understanding of CBD as a safe molecule, something that cannot be said of WIN55212,2 and other synthetic cannabinoid agonists.

In summary, the research team offered the following conclusion: “Our results reinforce the role of the endocannabinoid system in the sensorimotor gating impairment related to schizophrenia, and point to cannabinoid drugs as potential therapeutic strategies.”

Of course, FDA-approved clinical trials will likely be required before medical marijuana is permitted for schizophrenia treatment in America.

Loading Comments... ([[ count ]]) Comments
Leave a reply...

There are currently no comments for this topic. Be the first to leave a comment!

  • Want to stay in the loop?

    Join over 30,000 e-mail subscribers!

    By clicking submit I agree to the Privacy Policy

    Top cannabinoids

    Free Join the MJ Directory

    Welcome to the free database of cannabis companies, people, and events that anyone can add to. Ready to join the movement?

    Additional Reading View more
    Study: What Is The Best Cannabis Oil Extraction Method?
    Study: What Is The Best Cannabis Oil Extraction Method?
    Researchers Test Efficacy Of Various Cannabis Extract Solvents To Decide What Is The Best Cannabis Oil Extraction Method
    Study: Orally Administered THC May Help Treat PTSD
    Orally Absorbable THC May Improve PTSD Symptoms
    An Israeli study showed significant improvement in Post-Traumatic Stress Disorder (PTSD) symptoms when prescribed THC orally.
    Study: Cannabidivarin (CBDV) May Help Treat Epileptic Seizures
    CBDV Shows Promise Relieving Seizure Activity
    The Endocannabinoid Research Group in Italy published a study showing cannabidivarin could help modulate epileptiform activity in more ways than one.
    Medical Marijuana and Lupus: What You Need to Know
    Dr. Sean Breen Discusses Medical Marijuana and Lupus
    Medical director Dr. Sean Breen of Medical Cannabis of Southern California discusses that success of a patient using cannabis to treat lupus.

    Join thousands of other cannabis patients. Create an account Welcome back, [[ ]]! Access your Dashboard

    Your browser is out-of-date!

    Update your browser to view this website correctly. Update my browser now